There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Adults and adolescents were included in 3 phase 3 omalizumab trials in chronic idiopathic
urticaria (CIU): ASTERIA I, ASTERIA II, and GLACIAL.